Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
September 10, 2019
A former top pick. It's had a nice run this year. It's a real estate service company transforming into a tech, the Bloomberg of real estate, that's growing by double-digits. A good one to hold for the long run. Good managers.
Altus Group (AIF-T)
September 10, 2019
A former top pick. It's had a nice run this year. It's a real estate service company transforming into a tech, the Bloomberg of real estate, that's growing by double-digits. A good one to hold for the long run. Good managers.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$37.800
Owned
Yes
COMMENT
COMMENT
September 10, 2019

He met the company last year. Similar to DIV-T, comprised of many businesses, and you buy this for the dividend. There are some good businesses here, but valuing those companies can be difficult. Good for dividend investors.

Exchange Income (EIF-T)
September 10, 2019

He met the company last year. Similar to DIV-T, comprised of many businesses, and you buy this for the dividend. There are some good businesses here, but valuing those companies can be difficult. Good for dividend investors.

Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$37.690
Owned
No
PAST TOP PICK
PAST TOP PICK
September 10, 2019
(A Top Pick Sep 24/18, Down 68%) He still likes it. It's the biggest specialty pharma distributor of meds to seniors residences in Canada. The stock got hammered recently, because they didn't get the price the market expected for selling the surgery clinics (the deal closes Sept. 30). Still, they will pay down a lot of debt with this deal. The new CEO has done a fantastic job by cutting costs and increasing gross margins, but the market is ignoring this. Their EBITDA is growing. When the sale closes, he'll buy more stock.
Centric Health (CHH-T)
September 10, 2019
(A Top Pick Sep 24/18, Down 68%) He still likes it. It's the biggest specialty pharma distributor of meds to seniors residences in Canada. The stock got hammered recently, because they didn't get the price the market expected for selling the surgery clinics (the deal closes Sept. 30). Still, they will pay down a lot of debt with this deal. The new CEO has done a fantastic job by cutting costs and increasing gross margins, but the market is ignoring this. Their EBITDA is growing. When the sale closes, he'll buy more stock.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$0.130
Owned
Yes
PAST TOP PICK
PAST TOP PICK
September 10, 2019
(A Top Pick Sep 24/18, Up 51%) Short-sellers were spreading rumours about it, and he's long defended Badger. It now has the valuation it deserves. It's still reasonably priced. Well-managed with a huge organic runway of growth ahead. They're buying back a lot of shares.
Badger Daylighting (BAD-T)
September 10, 2019
(A Top Pick Sep 24/18, Up 51%) Short-sellers were spreading rumours about it, and he's long defended Badger. It now has the valuation it deserves. It's still reasonably priced. Well-managed with a huge organic runway of growth ahead. They're buying back a lot of shares.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$42.150
Owned
Yes
PAST TOP PICK
PAST TOP PICK
September 10, 2019
(A Top Pick Sep 24/18, Down 66%) The benefitted a lot a few years ago from selling their bus to the Canadian public transit market and the US private market. That bus was durable and fuel-efficient and beating competition; big parts of it are made in China. So, when the US launched the trade war, it hurt BUS-X. BUS has found a US partner now, but this makes the sales cycle much longer. That's why he sold.
(A Top Pick Sep 24/18, Down 66%) The benefitted a lot a few years ago from selling their bus to the Canadian public transit market and the US private market. That bus was durable and fuel-efficient and beating competition; big parts of it are made in China. So, when the US launched the trade war, it hurt BUS-X. BUS has found a US partner now, but this makes the sales cycle much longer. That's why he sold.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$0.420
Owned
No
DON'T BUY
DON'T BUY
September 10, 2019
A turnaround story. They carry a lot of debt after a bad acquisition, so be careful here. You need to have a strong stomach to buy this. Avoid it and look elsewhere.
Maxar Technologies (MAXR-T)
September 10, 2019
A turnaround story. They carry a lot of debt after a bad acquisition, so be careful here. You need to have a strong stomach to buy this. Avoid it and look elsewhere.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$10.910
Owned
No
DON'T BUY
DON'T BUY
September 10, 2019
A very expensive stock. It's grown by acquisition with some organic growth. Too rich for him. There is some cyclicality, as during the Recession, with less garbage produced, and there's an environmental push for less garbage. Well-managed, though, and in a good business.
Waste Connections (WCN-T)
September 10, 2019
A very expensive stock. It's grown by acquisition with some organic growth. Too rich for him. There is some cyclicality, as during the Recession, with less garbage produced, and there's an environmental push for less garbage. Well-managed, though, and in a good business.
Stephen Takacsy, B. Eng, MBA
Chief Investment Officer & Portfolio Mgr, Lester Asset Management
Price
$117.070
Owned
No